Thyrocare Technologies Limited (BOM:539871)
539.95
+5.80 (1.09%)
At close: Jun 19, 2026
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 86.7 billion as of June 22, 2026. Its market cap has increased by 55.75% in one year.
Market Cap
86.70B
Enterprise Value
85.31B
Revenue
8.29B
Ranking
n/a
PE Ratio
53.33
Stock Price
539.95
Market Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 86.70B, an increase of 161.13%. That is a compound annual growth rate of 9.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 85.94B | 21.07% |
| Dec 31, 2025 | 70.99B | 46.48% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| One Global Service Provider | 13.01B |
| Chandan Healthcare | 5.16B |
| Star Imaging and Path Lab | 1.42B |
| Aspira Pathlab & Diagnostics | 1.26B |
| Modern Diagnostic & Research Centre | 815.36M |
| Invicta Diagnostic | 814.04M |
| Family Care Hospitals | 164.75M |
| Clinitech Laboratory | 94.26M |